Form 4: Boston Scientific CEO Michael Mahoney Reports Stock Transactions
SEC Form 4 Filing
Michael Mahoney, Chairman, President & CEO of Boston Scientific, reports the vesting and conversion of performance share units and associated stock transactions.
Summary
- On January 1, 2025, Michael Mahoney, the Chairman, President & CEO of Boston Scientific, reported transactions involving Boston Scientific common stock and performance share units.
- Mahoney converted 57,121 performance share units into common stock.
- He also disposed of 25,656 shares to cover tax obligations at a price of $89.32 per share.
- Following these transactions, Mahoney directly owns 1,552,670 shares of Boston Scientific common stock and indirectly owns 201,478 shares through a trust.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, and does not inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into the executive's holdings and transactions in the company's stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in the number of outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 02/10/2022 | Reporting person was awarded a target number of performance share units under the Company's 2022 Free Cash Flow Performance Share Program |
| 12/31/2022 | End of the one-year performance period for the 2022 Free Cash Flow Performance Share Program. |
| 02/14/2023 | The number of the target performance share units as to which the performance criteria had been satisfied was determined. |
| 12/31/2024 | Completion of the three-year individual service period, vesting the performance share units. |
| 01/01/2025 | Date of transactions: conversion of performance share units and disposal of shares for tax obligations. |
| 01/03/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.